Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.37 trillion and total revenue of $115.79 billion.
Market Cap
1.37T
Revenue
115.79B
Profits
-38.78B
PE Ratio
n/a
Profit Margin
-33.49%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 141.42B | 0.22% | 800,964 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 84.22B | -1.00% | 496,255 | 15.53B |
| 3 | ARGX | argenx SE | 66.32B | -0.18% | 210,439 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 59.43B | -1.29% | 13,290,379 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 45.20B | 0.78% | 1,119,611 | - |
| 6 | ONC | BeOne Medicines AG | 41.24B | 0.25% | 123,618 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 36.73B | 1.22% | 2,761,485 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.39B | -1.08% | 1,710,078 | 4.80B |
| 9 | INSM | Insmed Incorporated | 27.66B | 0.04% | 1,885,699 | 1.14B |
| 10 | INCY | Incyte Corporation | 25.95B | -0.64% | 910,226 | 5.82B |
| 11 | BNTX | BioNTech SE | 25.84B | -0.90% | 1,180,897 | 3.03B |
| 12 | ROIV | Roivant Sciences Ltd. | 24.86B | 0.67% | 6,859,196 | 7.53M |
| 13 | GMAB | Genmab A/S | 20.40B | 0.56% | 890,948 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.81B | 1.43% | 1,019,245 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.07B | 0.81% | 507,617 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.74B | -1.42% | 1,098,135 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 14.65B | 1.03% | 2,141,585 | 2.44B |
| 18 | SMMT | Summit Therapeutics Inc. | 13.67B | 17.33% | 14,922,227 | - |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.86B | -0.81% | 1,478,211 | 3.41B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.57B | 1.00% | 1,889,665 | 1.66B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.54B | -0.79% | 143,455 | 1.28B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.22B | 1.31% | 1,370,551 | 669.50M |
| 23 | CORT | Corcept Therapeutics Incorporated | 12.19B | 2.15% | 611,215 | 830.81M |
| 24 | TECH | Bio-Techne Corporation | 11.36B | 0.21% | 2,542,976 | 1.22B |
| 25 | KRYS | Krystal Biotech, Inc. | 11.00B | 0.61% | 226,492 | 440.48M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 10.91B | -0.75% | 558,821 | 776.57M |
| 27 | ABVX | ABIVAX Société Anonyme | 10.78B | 2.66% | 1,111,818 | 5.67M |
| 28 | CYTK | Cytokinetics, Incorporated | 10.28B | 2.81% | 1,589,734 | 67.67M |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 9.92B | -0.66% | 200,750 | 7.46M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.75B | -1.14% | 591,615 | 105.00M |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 9.66B | -5.22% | 4,347,908 | 874.09M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 9.63B | 1.86% | 354,191 | 281.99M |
| 33 | PCVX | Vaxcyte, Inc. | 9.10B | -0.67% | 736,473 | - |
| 34 | IBRX | ImmunityBio, Inc. | 8.68B | 3.02% | 5,271,763 | 165.79M |
| 35 | IMVT | Immunovant, Inc. | 8.08B | -0.94% | 1,235,430 | - |
| 36 | TGTX | TG Therapeutics, Inc. | 8.04B | -0.33% | 1,571,491 | 799.54M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 7.69B | 0.23% | 1,054,195 | - |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.22B | -0.50% | 269,772 | 239.92M |
| 39 | CAI | Caris Life Sciences, Inc. | 7.16B | 2.10% | 6,431,870 | 989.61M |
| 40 | BLTE | Belite Bio, Inc | 6.89B | 6.49% | 203,422 | - |
| 41 | SRRK | Scholar Rock Holding Corporation | 6.81B | -0.29% | 803,487 | - |
| 42 | CGON | CG Oncology, Inc. | 6.59B | -0.35% | 359,674 | 6.23M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | 0.80% | 453,040 | 618.07M |
| 44 | TVTX | Travere Therapeutics, Inc. | 6.27B | -1.03% | 1,114,927 | 591.33M |
| 45 | COGT | Cogent Biosciences, Inc. | 6.07B | 1.10% | 1,268,646 | - |
| 46 | DNTH | Dianthus Therapeutics, Inc. | 6.03B | 1.52% | 355,693 | 1.90M |
| 47 | ORKA | Oruka Therapeutics, Inc. | 6.02B | -0.70% | 732,598 | - |
| 48 | PTCT | PTC Therapeutics, Inc. | 5.96B | -0.54% | 654,522 | 1.01B |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.85B | 0.40% | 471,701 | 7.50M |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.78B | 0.98% | 190,729 | 290.54M |
| 51 | ERAS | Erasca, Inc. | 5.69B | -0.67% | 3,762,017 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.46B | -0.76% | 1,491,346 | 13.39M |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.11B | -2.31% | 1,529,869 | - |
| 54 | PBLS | Parabilis Medicines, Inc. | 5.03B | 1.60% | 408,283 | 148.00K |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.80B | -3.70% | 1,849,411 | 1.14B |
| 56 | CELC | Celcuity Inc. | 4.72B | 0.24% | 773,238 | - |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.66B | -0.76% | 1,453,471 | - |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.56B | -0.07% | 976,765 | - |
| 59 | ELVN | Enliven Therapeutics, Inc. | 4.37B | 1.08% | 806,070 | - |
| 60 | LEGN | Legend Biotech Corporation | 4.21B | -0.64% | 1,317,286 | 1.27B |
| 61 | RLAY | Relay Therapeutics, Inc. | 4.17B | 2.70% | 2,716,789 | 10.35M |
| 62 | MANE | Veradermics, Incorporated | 4.08B | -0.72% | 356,928 | - |
| 63 | TLX | Telix Pharmaceuticals Limited | 3.98B | 2.53% | 139,775 | 890.79M |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.96B | 1.43% | 1,394,493 | - |
| 65 | IOVA | Iovance Biotherapeutics, Inc. | 3.94B | 0.93% | 14,637,233 | 324.97M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.86B | -0.50% | 567,895 | 234.13M |
| 67 | TNGX | Tango Therapeutics, Inc. | 3.84B | 1.97% | 1,343,712 | 53.81M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.84B | 0.94% | 681,696 | 117.00M |
| 69 | ABCL | AbCellera Biologics Inc. | 3.75B | 1.85% | 3,291,672 | 66.17M |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.65B | 0.54% | 733,747 | 606.33M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.64B | -0.22% | 1,727,982 | 3.60M |
| 72 | GPCR | Structure Therapeutics Inc. | 3.38B | -0.96% | 621,487 | - |
| 73 | QURE | uniQure N.V. | 3.11B | -2.96% | 1,321,833 | 18.67M |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.09B | -0.28% | 417,999 | 158.00K |
| 75 | NAMS | NewAmsterdam Pharma Company N.V. | 3.09B | 1.02% | 581,376 | 7.12M |
| 76 | IMNM | Immunome, Inc. | 3.08B | -0.62% | 796,416 | 4.02M |
| 77 | IRON | Disc Medicine, Inc. | 3.05B | -0.85% | 503,911 | - |
| 78 | ZLAB | Zai Lab Limited | 3.03B | 1.96% | 585,713 | 449.61M |
| 79 | ARQT | Arcutis Biotherapeutics, Inc. | 2.97B | -0.80% | 1,122,317 | 463.98M |
| 80 | MBX | MBX Biosciences, Inc. | 2.96B | 0.87% | 292,658 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.94B | 0.58% | 1,271,299 | 156.04M |
| 82 | SLS | SELLAS Life Sciences Group, Inc. | 2.77B | -3.25% | 5,783,361 | - |
| 83 | ATAI | AtaiBeckley Inc. | 2.72B | -0.14% | 17,481,661 | 4.47M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.63B | -1.94% | 1,381,489 | 36.77M |
| 85 | NKTR | Nektar Therapeutics | 2.61B | 4.99% | 691,273 | 54.59M |
| 86 | VRDN | Viridian Therapeutics, Inc. | 2.60B | 0.79% | 1,193,895 | 71.13M |
| 87 | PGEN | Precigen, Inc. | 2.56B | 1.85% | 2,188,672 | 85.72M |
| 88 | VERA | Vera Therapeutics, Inc. | 2.52B | -1.88% | 929,048 | - |
| 89 | PHVS | Pharvaris N.V. | 2.50B | 1.39% | 357,063 | - |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.50B | -2.65% | 1,325,735 | - |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.44B | -2.33% | 1,100,645 | 959.90M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.43B | 0.06% | 1,428,042 | - |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.43B | -0.95% | 2,768,346 | 1.97B |
| 94 | BHVN | Biohaven Ltd. | 2.40B | 1.08% | 2,259,496 | - |
| 95 | NUVB | Nuvation Bio Inc. | 2.38B | -2.31% | 5,275,583 | 169.90M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 2.34B | -2.39% | 2,128,709 | 52.06M |
| 97 | RAPP | Rapport Therapeutics, Inc. | 2.29B | -2.14% | 276,963 | 20.00M |
| 98 | KOD | Kodiak Sciences Inc. | 2.28B | -3.04% | 460,191 | - |
| 99 | PVLA | Palvella Therapeutics, Inc. | 2.24B | 1.65% | 249,669 | - |
| 100 | MESO | Mesoblast Limited | 2.22B | -0.87% | 86,064 | 120.25M |
| 101 | URGN | UroGen Pharma Ltd. | 2.19B | 1.04% | 877,798 | 188.73M |
| 102 | ADMA | ADMA Biologics, Inc. | 2.15B | 0.74% | 1,326,117 | 512.28M |
| 103 | ZBIO | Zenas BioPharma, Inc. | 2.15B | -0.63% | 515,117 | 1.00M |
| 104 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -1.04% | 752,561 | 311.51M |
| 105 | ZYME | Zymeworks Inc. | 2.12B | -3.70% | 790,935 | 37.13M |
| 106 | GENB | Generate Biomedicines, Inc. | 2.10B | 0.37% | 964,048 | 26.48M |
| 107 | COAG | Hemab Therapeutics Holdings, Inc. | 2.07B | -0.74% | 257,209 | - |
| 108 | VCEL | Vericel Corporation | 2.07B | -1.03% | 301,274 | 306.30M |
| 109 | KLRA | Kailera Therapeutics, Inc. | 2.04B | -0.69% | 642,523 | - |
| 110 | NBTX | Nanobiotix S.A. | 2.01B | -4.01% | 97,040 | 38.27M |
| 111 | XNCR | Xencor, Inc. | 1.98B | -1.04% | 1,321,481 | 104.97M |
| 112 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -2.93% | 516,035 | 98.34M |
| 113 | KARD | Kardigan, Inc. | 1.94B | -5.38% | 262,836 | - |
| 114 | VIR | Vir Biotechnology, Inc. | 1.94B | -0.43% | 2,565,559 | 303.23M |
| 115 | STOK | Stoke Therapeutics, Inc. | 1.94B | -1.67% | 512,255 | 27.59M |
| 116 | IMCR | Immunocore Holdings plc | 1.93B | 0.54% | 245,974 | 430.78M |
| 117 | GHRS | GH Research PLC | 1.92B | -0.53% | 116,967 | - |
| 118 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.91B | -0.14% | 2,907,997 | 208.78M |
| 119 | LKFT | Lakefront Biotherapeutics NV | 1.89B | 0.73% | 394,301 | 1.13B |
| 120 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | -0.48% | 1,920,719 | 252.25M |
| 121 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | 1.78% | 13,746,068 | 54.86M |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | -1.24% | 1,878,079 | 5.49M |
| 123 | INBX | Inhibrx Biosciences, Inc. | 1.80B | -2.17% | 151,714 | 1.30M |
| 124 | SLBT | SL Science Holding Limited | 1.80B | -4.83% | 115,084 | 3.27M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.78B | -0.63% | 3,004,965 | 59.51M |
| 126 | FTRE | Fortrea Holdings Inc. | 1.77B | 1.42% | 776,309 | 2.68B |
| 127 | DMRA | Damora Therapeutics, Inc. | 1.73B | -0.64% | 328,157 | - |
| 128 | SEPN | Septerna, Inc. | 1.72B | -1.87% | 241,561 | 98.88M |
| 129 | NVAX | Novavax, Inc. | 1.71B | 0.19% | 6,226,631 | 413.80M |
| 130 | ANAB | AnaptysBio, Inc. | 1.70B | 2.90% | 366,847 | 232.39M |
| 131 | BRVE | Braveheart Bio, Inc. | 1.69B | -2.52% | 327,571 | - |
| 132 | AAPG | Ascentage Pharma Group International | 1.61B | 3.27% | 10,093 | 94.61M |
| 133 | AVLN | Avalyn Pharma Inc. | 1.57B | -0.39% | 150,941 | - |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.54B | -0.93% | 259,737 | - |
| 135 | INVA | Innoviva, Inc. | 1.54B | - | 612,463 | 440.00M |
| 136 | APMD | Apnimed, Inc. | 1.54B | -0.07% | 234,263 | 120.15M |
| 137 | LBRX | LB Pharmaceuticals Inc | 1.53B | -3.96% | 282,475 | - |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.53B | 1.70% | 465,360 | - |
| 139 | TRAX | First Tracks Biotherapeutics, Inc. | 1.52B | -6.12% | 717,078 | - |
| 140 | ABSI | Absci Corporation | 1.51B | - | 2,753,314 | 1.56M |
| 141 | TYRA | Tyra Biosciences, Inc. | 1.48B | -1.07% | 603,552 | - |
| 142 | AKTS | Aktis Oncology, Inc. | 1.48B | -1.00% | 152,776 | 10.06M |
| 143 | ALMS | Alumis Inc. | 1.47B | 9.76% | 7,550,084 | 7.40M |
| 144 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -44.03% | 27,159,724 | 717.00M |
| 145 | REPL | Replimune Group, Inc. | 1.44B | -4.32% | 1,353,768 | - |
| 146 | MAZE | Maze Therapeutics, Inc. | 1.44B | -3.18% | 477,429 | 20.00M |
| 147 | VOR | Vor Biopharma Inc. | 1.43B | -2.10% | 538,763 | - |
| 148 | ANRO | Alto Neuroscience, Inc. | 1.43B | -0.66% | 324,658 | - |
| 149 | CGEM | Cullinan Therapeutics, Inc. | 1.43B | -0.76% | 524,125 | - |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.42B | 3.26% | 229,299 | - |
| 151 | OMER | Omeros Corporation | 1.38B | 1.33% | 1,165,466 | 38.42M |
| 152 | SVRA | Savara Inc. | 1.36B | -1.65% | 1,240,413 | - |
| 153 | DRTS | Alpha Tau Medical Ltd. | 1.35B | 2.02% | 630,232 | - |
| 154 | MGTX | MeiraGTx Holdings plc | 1.34B | -0.64% | 824,114 | 397.50M |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | 1.32B | -2.97% | 916,442 | - |
| 156 | SPTX | Seaport Therapeutics, Inc. | 1.30B | -2.49% | 86,222 | - |
| 157 | IMTX | Immatics N.V. | 1.29B | -0.42% | 494,337 | 47.65M |
| 158 | MLTX | MoonLake Immunotherapeutics | 1.29B | 0.86% | 841,991 | - |
| 159 | MNKD | MannKind Corporation | 1.27B | -1.98% | 2,331,114 | 393.63M |
| 160 | ODTX | Odyssey Therapeutics, Inc. | 1.27B | -0.83% | 189,635 | 99.00K |
| 161 | JBIO | Jade Biosciences, Inc. | 1.26B | -7.24% | 1,381,784 | - |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | 3.17% | 938,430 | - |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 1.23B | 1.13% | 672,733 | 28.73M |
| 164 | JANX | Janux Therapeutics, Inc. | 1.21B | 0.51% | 1,686,576 | 24.00M |
| 165 | SANA | Sana Biotechnology, Inc. | 1.17B | 0.77% | 2,639,107 | - |
| 166 | KURA | Kura Oncology, Inc. | 1.17B | 0.31% | 1,477,984 | 77.23M |
| 167 | IVA | Inventiva S.A. | 1.13B | -0.41% | 1,041,890 | 7.94M |
| 168 | SLDB | Solid Biosciences Inc. | 1.12B | 1.26% | 728,483 | - |
| 169 | OBX | Obsidian Therapeutics, Inc. | 1.06B | 0.53% | 136,232 | - |
| 170 | ATTO | Attovia Therapeutics, Inc. | 1.04B | 4.63% | 192,775 | 1.35M |
| 171 | AVTX | Avalo Therapeutics, Inc. | 1.02B | -1.76% | 674,036 | 59.00K |
| 172 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.39% | 3,226,790 | 181.72M |
| 173 | FTH | Faeth Therapeutics, Inc. | 1.01B | -0.31% | 175,185 | - |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.01B | 0.89% | 1,510,144 | 41.47M |
| 175 | CADL | Candel Therapeutics, Inc. | 992.45M | -1.74% | 628,313 | - |
| 176 | IMMX | Immix Biopharma, Inc. | 989.39M | -0.93% | 987,216 | - |
| 177 | GERN | Geron Corporation | 970.13M | -5.03% | 14,234,298 | 204.56M |
| 178 | SGP | SpyGlass Pharma, Inc. | 969.66M | 2.51% | 82,809 | - |
| 179 | ANL | Adlai Nortye Group Ltd. | 949.87M | 6.42% | 77,055 | 18.06M |
| 180 | DSGN | Design Therapeutics, Inc. | 940.60M | -3.22% | 376,169 | - |
| 181 | OLMA | Olema Pharmaceuticals, Inc. | 938.85M | -0.92% | 773,317 | - |
| 182 | WVE | Wave Life Sciences, Inc. | 926.13M | -3.69% | 6,161,971 | 65.37M |
| 183 | ARDX | Ardelyx, Inc. | 924.49M | -2.37% | 3,470,482 | 450.89M |
| 184 | ANNX | Annexon, Inc. | 917.56M | -1.83% | 2,313,562 | - |
| 185 | RIGL | Rigel Pharmaceuticals, Inc. | 905.97M | -1.86% | 190,390 | 276.79M |
| 186 | SLN | Silence Therapeutics plc | 890.50M | - | 572,407 | 615.00K |
| 187 | TBPH | Theravance Biopharma, Inc. | 886.77M | 0.06% | 301,866 | 104.31M |
| 188 | ACRS | Aclaris Therapeutics, Inc. | 875.83M | -3.72% | 1,392,062 | 8.22M |
| 189 | CBIO | Crescent Biopharma, Inc. | 873.14M | 10.03% | 773,533 | 11.88M |
| 190 | HELP | Cybin Inc. | 859.92M | -1.51% | 820,944 | - |
| 191 | ACHV | Achieve Life Sciences, Inc. | 855.12M | -2.00% | 1,532,541 | - |
| 192 | CLYM | Climb Bio, Inc. | 837.99M | -3.06% | 5,527,183 | - |
| 193 | DBVT | DBV Technologies S.A. | 813.73M | 0.66% | 145,248 | 5.04M |
| 194 | FDMT | 4D Molecular Therapeutics, Inc. | 812.09M | -1.61% | 782,447 | 92.01M |
| 195 | CTMX | CytomX Therapeutics, Inc. | 801.87M | -1.08% | 2,557,826 | 18.30M |
| 196 | PHAR | Pharming Group N.V. | 800.74M | 2.32% | 5,350 | 366.48M |
| 197 | MNPR | Monopar Therapeutics Inc. | 795.73M | 1.95% | 208,568 | - |
| 198 | NVCT | Nuvectis Pharma, Inc. | 794.01M | 1.88% | 135,967 | - |
| 199 | AURA | Aura Biosciences, Inc. | 764.30M | -1.73% | 875,875 | - |
| 200 | NGNE | Neurogene Inc. | 752.63M | -1.96% | 255,222 | 925.00K |
| 201 | OCS | Oculis Holding AG | 751.28M | 1.25% | 179,234 | 1.45M |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 744.67M | 1.95% | 890,552 | 136.07M |
| 203 | ASMB | Assembly Biosciences, Inc. | 735.63M | -1.61% | 224,976 | 74.85M |
| 204 | AGMB | AgomAb Therapeutics NV | 730.35M | 8.57% | 407,964 | - |
| 205 | MPLT | MapLight Therapeutics, Inc. | 730.26M | 0.61% | 863,544 | - |
| 206 | VSTM | Verastem, Inc. | 722.70M | -0.50% | 2,627,110 | 87.53M |
| 207 | PHAT | Phathom Pharmaceuticals, Inc. | 718.84M | -2.27% | 663,058 | 239.66M |
| 208 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 713.55M | 0.11% | 139,211 | - |
| 209 | STTK | Shattuck Labs, Inc. | 698.53M | 0.72% | 563,925 | 1.00M |
| 210 | OABI | OmniAb, Inc. | 690.60M | -5.75% | 2,011,180 | 38.46M |
| 211 | ALLO | Allogene Therapeutics, Inc. | 684.07M | - | 4,425,096 | 4.64M |
| 212 | GYRE | Gyre Therapeutics, Inc. | 682.86M | 1.26% | 41,206 | 109.82M |
| 213 | SGMT | Sagimet Biosciences Inc. | 678.77M | -0.64% | 1,142,063 | - |
| 214 | DRUG | Bright Minds Biosciences Inc. | 674.50M | -4.36% | 131,268 | - |
| 215 | VALN | Valneva SE | 664.34M | -0.84% | 40,873 | 163.30M |
| 216 | CTNM | Contineum Therapeutics, Inc. | 661.00M | 1.91% | 320,781 | - |
| 217 | CRMD | CorMedix Inc. | 660.19M | -1.63% | 707,674 | 462.25M |
| 218 | PRME | Prime Medicine, Inc. | 660.02M | 1.09% | 2,312,568 | 4.07M |
| 219 | MDXG | MiMedx Group, Inc. | 645.72M | -2.64% | 841,629 | 355.17M |
| 220 | ALT | Altimmune, Inc. | 628.29M | -1.52% | 2,552,091 | 31.00K |
| 221 | BLSM | BlossomHill Therapeutics, Inc. | 613.49M | 3.30% | 97,322 | - |
| 222 | AUTL | Autolus Therapeutics plc | 609.51M | 2.23% | 1,910,186 | 117.39M |
| 223 | ARVN | Arvinas, Inc. | 608.75M | -2.92% | 501,476 | 316.70M |
| 224 | RGNX | REGENXBIO Inc. | 607.32M | -4.17% | 839,249 | 174.48M |
| 225 | EIKN | Eikon Therapeutics, Inc. | 593.65M | -3.69% | 384,279 | - |
| 226 | CABA | Cabaletta Bio, Inc. | 590.02M | -2.52% | 7,437,331 | - |
| 227 | TECX | Tectonic Therapeutic, Inc. | 584.92M | -1.51% | 140,388 | - |
| 228 | SCTX | Scribe Therapeutics Inc. | 581.21M | -0.29% | 148,448 | 36.28M |
| 229 | PROK | ProKidney Corp. | 580.46M | 0.52% | 751,467 | 818.00K |
| 230 | SPRY | ARS Pharmaceuticals, Inc. | 563.87M | -2.58% | 1,088,188 | 116.93M |
| 231 | ZURA | Zura Bio Limited | 563.48M | 3.70% | 1,776,132 | - |
| 232 | ARTV | Artiva Biotherapeutics, Inc. | 543.90M | -1.64% | 365,624 | 251.00K |
| 233 | OVID | Ovid Therapeutics Inc. | 542.93M | 2.58% | 1,361,893 | 1.58M |
| 234 | PRLD | Prelude Therapeutics Incorporated | 540.72M | -3.31% | 577,964 | 22.42M |
| 235 | CAPR | Capricor Therapeutics, Inc. | 539.53M | -6.17% | 4,064,905 | 11.13M |
| 236 | KYTX | Kyverna Therapeutics, Inc. | 516.39M | -3.13% | 595,293 | - |
| 237 | ENTX | Entera Bio Ltd. | 510.77M | 1.03% | 154,038 | 42.00K |
| 238 | EPRX | Eupraxia Pharmaceuticals Inc. | 495.22M | 0.67% | 401,900 | - |
| 239 | PRTA | Prothena Corporation plc | 492.83M | -0.93% | 277,056 | 54.53M |
| 240 | PBYI | Puma Biotechnology, Inc. | 485.74M | -2.89% | 244,320 | 231.24M |
| 241 | RZLT | Rezolute, Inc. | 474.28M | -0.44% | 771,933 | - |
| 242 | EDIT | Editas Medicine, Inc. | 473.03M | - | 1,378,261 | 47.01M |
| 243 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.01M | -1.14% | 860,360 | 132.42M |
| 244 | AVIR | Atea Pharmaceuticals, Inc. | 466.79M | 2.11% | 198,520 | - |
| 245 | RLMD | Relmada Therapeutics, Inc. | 466.15M | -3.74% | 847,511 | - |
| 246 | CCCC | C4 Therapeutics, Inc. | 460.11M | -1.32% | 2,228,465 | 35.04M |
| 247 | IKT | Inhibikase Therapeutics, Inc. | 458.83M | 0.80% | 564,219 | 1.00 |
| 248 | OCGN | Ocugen, Inc. | 457.80M | 2.27% | 2,416,083 | 4.58M |
| 249 | VOGX | Vogenx, Inc. | 447.45M | 0.16% | 76,263 | - |
| 250 | ARCT | Arcturus Therapeutics Holdings Inc. | 442.26M | -7.05% | 849,068 | 29.37M |
| 251 | FENC | Fennec Pharmaceuticals Inc. | 440.09M | 1.95% | 296,105 | 59.22M |
| 252 | GALT | Galectin Therapeutics Inc. | 438.70M | -2.90% | 244,150 | - |
| 253 | EVMN | Evommune, Inc. | 435.51M | -3.85% | 594,236 | 10.00M |
| 254 | BNTC | Benitec Biopharma Inc. | 427.37M | -3.42% | 62,612 | - |
| 255 | CMPX | Compass Therapeutics, Inc. | 426.81M | -2.47% | 2,559,953 | 850.00K |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 416.05M | -1.81% | 1,071,388 | - |
| 257 | VTVT | vTv Therapeutics Inc. | 415.86M | 0.21% | 20,870 | 36.84M |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 408.34M | -0.50% | 239,350 | 65.26M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 400.55M | - | 409,441 | 15.85M |
| 260 | LRMR | Larimar Therapeutics, Inc. | 399.79M | -1.03% | 684,259 | - |
| 261 | LXEO | Lexeo Therapeutics, Inc. | 397.09M | 1.26% | 313,345 | - |
| 262 | EYPT | EyePoint, Inc. | 393.56M | -4.70% | 2,625,997 | 2.79M |
| 263 | ZNTL | Zentalis Pharmaceuticals, Inc. | 389.10M | 9.02% | 1,366,548 | 26.87M |
| 264 | IRD | Opus Genetics, Inc. | 382.70M | 3.37% | 4,425,605 | 9.86M |
| 265 | QTTB | Q32 Bio Inc. | 381.05M | -5.81% | 491,580 | 53.74M |
| 266 | IPSC | Century Therapeutics, Inc. | 378.45M | -0.95% | 349,612 | 109.16M |
| 267 | AGEN | Agenus Inc. | 370.97M | 1.85% | 738,723 | 132.69M |
| 268 | PALI | Palisade Bio, Inc. | 356.38M | 2.76% | 1,087,073 | 500.00K |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 353.75M | -2.81% | 116,145 | - |
| 270 | LYEL | Lyell Immunopharma, Inc. | 350.91M | -4.28% | 79,053 | 27.00K |
| 271 | STRO | Sutro Biopharma, Inc. | 340.58M | 0.34% | 158,118 | 45.70M |
| 272 | ABEO | Abeona Therapeutics Inc. | 339.10M | -0.34% | 862,020 | 25.52M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 338.47M | -0.80% | 161,592 | 114.70K |
| 274 | UPB | Upstream Bio, Inc. | 333.01M | -6.17% | 1,351,773 | 3.16M |
| 275 | IFRX | InflaRx N.V. | 328.63M | -2.62% | 666,375 | -11.54K |
| 276 | IMRX | Immuneering Corporation | 326.07M | 0.40% | 424,432 | - |
| 277 | VNDA | Vanda Pharmaceuticals Inc. | 322.87M | -3.44% | 756,161 | 215.72M |
| 278 | VCRE | Vicore Pharma Holding AB (publ) | 321.27M | 2.76% | 8,738 | 412.09K |
| 279 | SION | Sionna Therapeutics, Inc. | 305.18M | -7.66% | 1,243,913 | - |
| 280 | TTRX | Turn Therapeutics Inc. | 299.97M | 4.14% | 82,465 | - |
| 281 | CUVL | Clinuvel Pharmaceuticals Limited | 299.73M | 1.29% | 22,441 | 65.05M |
| 282 | PYXS | Pyxis Oncology, Inc. | 297.35M | -4.93% | 812,185 | 11.04M |
| 283 | BCYC | Bicycle Therapeutics plc | 296.77M | -1.40% | 268,065 | 61.21M |
| 284 | PRQR | ProQR Therapeutics N.V. | 294.94M | -2.79% | 697,400 | 21.05M |
| 285 | FULC | Fulcrum Therapeutics, Inc. | 292.98M | -0.26% | 1,436,136 | 80.00M |
| 286 | ACIU | AC Immune SA | 291.32M | 3.17% | 171,765 | 21.67M |
| 287 | FATE | Fate Therapeutics, Inc. | 289.97M | -1.22% | 715,438 | 6.49M |
| 288 | FHTX | Foghorn Therapeutics Inc. | 289.21M | -5.80% | 442,158 | 36.74M |
| 289 | OBIO | Orchestra BioMed Holdings, Inc. | 284.90M | -4.24% | 325,586 | 31.98M |
| 290 | CAMP | Camp4 Therapeutics Corporation | 281.76M | 18.16% | 1,280,634 | 4.22M |
| 291 | ALXO | ALX Oncology Holdings Inc. | 280.70M | -2.40% | 603,425 | - |
| 292 | ALEC | Alector, Inc. | 280.26M | -7.72% | 2,792,297 | 13.86M |
| 293 | LCTX | Lineage Cell Therapeutics, Inc. | 278.20M | -0.90% | 917,014 | 13.08M |
| 294 | RNAC | Cartesian Therapeutics, Inc. | 275.93M | 0.44% | 134,924 | 1.48M |
| 295 | MGNX | MacroGenics, Inc. | 270.73M | -1.62% | 478,600 | 175.14M |
| 296 | SRZN | Surrozen, Inc. | 264.93M | -0.27% | 200,873 | 11.51M |
| 297 | AVXL | Anavex Life Sciences Corp. | 264.19M | -1.38% | 421,923 | - |
| 298 | WHWK | Whitehawk Therapeutics, Inc. | 263.95M | -1.70% | 223,092 | 7.15M |
| 299 | TRDA | Entrada Therapeutics, Inc. | 258.53M | -1.78% | 395,559 | 4.69M |
| 300 | YDES | YD Bio Limited | 258.07M | -2.39% | 672,075 | 510.36K |
| 301 | NMRA | Neumora Therapeutics, Inc. | 253.66M | -2.17% | 386,040 | - |
| 302 | RNA | Atrium Therapeutics, Inc. | 249.74M | 3.84% | 164,906 | 35.84M |
| 303 | NGEN | NervGen Pharma Corp. | 249.45M | -0.43% | 434,342 | - |
| 304 | CLLS | Cellectis S.A. | 249.09M | 2.15% | 20,932 | 63.82M |
| 305 | ADAG | Adagene Inc. | 247.76M | - | 167,713 | 9.29M |
| 306 | NAGE | Niagen Bioscience, Inc. | 246.60M | -1.89% | 242,247 | 129.08M |
| 307 | IVVD | Invivyd, Inc. | 246.12M | 3.86% | 2,577,765 | 58.37M |
| 308 | CGEN | Compugen Ltd. | 242.02M | -2.85% | 163,618 | 74.00M |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 238.33M | -2.01% | 1,146,439 | - |
| 310 | TARA | Protara Therapeutics, Inc. | 234.61M | 0.76% | 239,457 | - |
| 311 | SLGL | Sol-Gel Technologies Ltd. | 229.51M | -0.47% | 58,072 | 1.80M |
| 312 | GLSI | Greenwich LifeSciences, Inc. | 229.42M | -0.70% | 46,668 | - |
| 313 | TNXP | Tonix Pharmaceuticals Holding Corp. | 229.31M | -0.07% | 264,362 | 29.10M |
| 314 | ANTX | AN2 Therapeutics, Inc. | 224.53M | - | 199,660 | - |
| 315 | NERV | Minerva Neurosciences, Inc. | 223.94M | 4.69% | 151,224 | - |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 223.46M | -0.32% | 453,411 | - |
| 317 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 221.65M | -0.17% | 475,360 | - |
| 318 | KROS | Keros Therapeutics, Inc. | 220.28M | -1.07% | 148,714 | 15.01M |
| 319 | PEPG | PepGen Inc. | 220.25M | - | 514,339 | - |
| 320 | VRXA | Veraxa Biotech AG | 216.35M | 10.87% | 561,195 | 29.54K |
| 321 | CHRS | Coherus Oncology, Inc. | 211.67M | -3.52% | 437,197 | 50.94M |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 211.10M | 1.16% | 942,013 | 80.62M |
| 323 | NBP | NovaBridge Biosciences | 208.80M | 0.56% | 165,454 | - |
| 324 | VYGR | Voyager Therapeutics, Inc. | 208.27M | -4.52% | 619,980 | 34.46M |
| 325 | ARMP | Armata Pharmaceuticals, Inc. | 205.24M | -0.18% | 49,497 | 5.54M |
| 326 | ORMP | Oramed Pharmaceuticals Inc. | 205.07M | -2.76% | 187,973 | 2.00M |
| 327 | DTIL | Precision BioSciences, Inc. | 203.42M | -1.07% | 186,995 | 45.06M |
| 328 | CUE | Cue Biopharma, Inc. | 201.01M | 2.63% | 65,684 | 37.66M |
| 329 | ACOG | Alpha Cognition Inc. | 200.57M | -1.18% | 90,804 | 15.26M |
| 330 | NKTX | Nkarta, Inc. | 199.83M | 0.90% | 730,085 | - |
| 331 | IPHA | Innate Pharma S.A. | 194.09M | -2.76% | 10,891 | 10.57M |
| 332 | MSLE | Satellos Bioscience Inc. | 192.81M | 0.33% | 27,482 | - |
| 333 | LENZ | LENZ Therapeutics, Inc. | 183.18M | 0.52% | 835,136 | 21.48M |
| 334 | CNTN | Canton Strategic Holdings, Inc. | 179.28M | 8.17% | 642,800 | 1.50M |
| 335 | IMUX | Immunic, Inc. | 174.10M | -10.39% | 841,955 | - |
| 336 | KRRO | Korro Bio, Inc. | 171.11M | -2.92% | 82,729 | 2.38M |
| 337 | MDWD | MediWound Ltd. | 170.54M | 1.15% | 91,161 | 11.86M |
| 338 | MIST | Milestone Pharmaceuticals Inc. | 170.50M | 2.54% | 2,029,409 | 2.34M |
| 339 | MENS | Jyong Biotech Ltd. | 168.51M | 0.89% | 40,359 | - |
| 340 | CRBU | Caribou Biosciences, Inc. | 168.32M | -1.88% | 1,349,960 | 10.04M |
| 341 | KZIA | Kazia Therapeutics Limited | 166.64M | -3.57% | 413,806 | 1.27M |
| 342 | MOLN | Molecular Partners AG | 166.05M | 6.88% | 282 | 856.30K |
| 343 | SPRB | Spruce Biosciences, Inc. | 165.86M | -3.28% | 116,624 | 697.00K |
| 344 | HUMA | Humacyte, Inc. | 165.57M | -0.10% | 3,016,735 | 2.12M |
| 345 | OTLK | Outlook Therapeutics, Inc. | 158.00M | 3.62% | 6,640,789 | -1.16M |
| 346 | TNYA | Tenaya Therapeutics, Inc. | 155.91M | -0.57% | 1,555,104 | 1.34M |
| 347 | CDXS | Codexis, Inc. | 155.50M | -3.73% | 1,010,688 | 77.68M |
| 348 | INDP | Indaptus Therapeutics, Inc. | 154.56M | -0.85% | 249,916 | - |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 148.39M | -0.87% | 237,363 | 3.39M |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 147.63M | 2.12% | 836,926 | - |
| 351 | OKUR | OnKure Therapeutics, Inc. | 144.17M | 0.56% | 132,190 | - |
| 352 | CNXU | Conexeu Sciences Inc. | 141.02M | -5.22% | 305,015 | - |
| 353 | EQ | Equillium, Inc. | 140.77M | -1.33% | 152,566 | 4.39M |
| 354 | INO | Inovio Pharmaceuticals, Inc. | 140.62M | - | 4,199,674 | 65.34K |
| 355 | BMEA | Biomea Fusion, Inc. | 138.44M | -1.29% | 1,759,412 | - |
| 356 | HURA | TuHURA Biosciences, Inc. | 133.83M | 0.48% | 114,280 | - |
| 357 | TLSA | Tiziana Life Sciences Ltd | 126.01M | 4.62% | 517,937 | - |
| 358 | AARD | Aardvark Therapeutics, Inc. | 125.40M | -3.70% | 89,324 | - |
| 359 | VANI | Vivani Medical, Inc. | 125.38M | -2.11% | 231,119 | - |
| 360 | ENGN | enGene Therapeutics Inc. | 122.59M | -3.17% | 634,652 | - |
| 361 | CNTB | Connect Biopharma Holdings Limited | 121.54M | -30.07% | 3,759,863 | 2.95M |
| 362 | CBUS | Cibus, Inc. | 120.76M | 1.28% | 107,013 | 4.35M |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 120.65M | -1.87% | 609,843 | 70.00M |
| 364 | NTHI | NeOnc Technologies Holdings, Inc. | 119.06M | -3.43% | 142,009 | 39.99K |
| 365 | RANI | Rani Therapeutics Holdings, Inc. | 118.79M | -0.68% | 392,227 | 4.88M |
| 366 | NAUT | Nautilus Biotechnology, Inc. | 117.01M | -4.40% | 795,836 | 190.00K |
| 367 | PMN | ProMIS Neurosciences, Inc. | 115.68M | -7.73% | 37,395 | - |
| 368 | GNLX | Genelux Corporation | 112.93M | -1.18% | 510,441 | 8.00K |
| 369 | GUTS | Fractyl Health, Inc. | 109.40M | -2.75% | 2,462,880 | 3.00K |
| 370 | ONCY | Oncolytics Biotech Inc. | 109.21M | -2.67% | 585,068 | - |
| 371 | SEER | Seer, Inc. | 107.42M | -2.02% | 67,750 | 14.22M |
| 372 | PYPD | PolyPid Ltd. | 107.04M | -0.57% | 65,917 | - |
| 373 | RNXT | RenovoRx, Inc. | 106.96M | -5.95% | 3,825,186 | 1.98M |
| 374 | COYA | Coya Therapeutics, Inc. | 106.73M | 2.94% | 100,315 | 8.02M |
| 375 | ANIX | Anixa Biosciences, Inc. | 103.77M | -2.56% | 409,261 | - |
| 376 | TENX | Tenax Therapeutics, Inc. | 101.96M | -3.78% | 14,092,406 | - |
| 377 | ACET | Adicet Bio, Inc. | 101.51M | 1.84% | 78,757 | - |
| 378 | CGTX | Cognition Therapeutics, Inc. | 99.85M | - | 261,506 | - |
| 379 | PLYX | Polaryx Therapeutics, Inc. | 99.19M | -2.45% | 21,103 | - |
| 380 | ATRA | Atara Biotherapeutics, Inc. | 95.66M | 0.95% | 25,276 | 6.19M |
| 381 | KLRS | Kalaris Therapeutics, Inc. | 93.79M | 1.03% | 39,987 | - |
| 382 | PMVP | PMV Pharmaceuticals, Inc. | 93.64M | -1.59% | 576,325 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 93.26M | -2.68% | 43,484 | 43.30M |
| 384 | VRCA | Verrica Pharmaceuticals Inc. | 92.08M | -0.56% | 55,386 | 30.32M |
| 385 | ICCC | ImmuCell Corporation | 90.82M | - | 14,265 | 30.68M |
| 386 | FBIO | Fortress Biotech, Inc. | 90.38M | -0.73% | 148,110 | 68.47M |
| 387 | RLYB | Rallybio Corporation | 89.61M | -0.38% | 2,508 | 646.00K |
| 388 | ALDX | Aldeyra Therapeutics, Inc. | 89.28M | -0.67% | 568,928 | - |
| 389 | ACRV | Acrivon Therapeutics, Inc. | 88.28M | -4.19% | 118,785 | - |
| 390 | GOSS | Gossamer Bio, Inc. | 85.84M | 1.68% | 5,729,696 | 53.29M |
| 391 | CRDF | Cardiff Oncology, Inc. | 84.02M | 1.89% | 376,194 | 508.00K |
| 392 | OSTX | OS Therapies Incorporated | 83.95M | 6.43% | 894,277 | - |
| 393 | IBIO | iBio, Inc. | 83.60M | -0.76% | 354,195 | 100.00K |
| 394 | OKYO | OKYO Pharma Limited | 81.34M | -4.32% | 9,332 | - |
| 395 | MAIA | MAIA Biotechnology, Inc. | 80.90M | -2.92% | 470,785 | - |
| 396 | YARW | Yarrow Bioscience, Inc. | 80.78M | -3.77% | 29,122 | - |
| 397 | DWTX | Dogwood Therapeutics, Inc. | 80.22M | -4.84% | 46,654 | - |
| 398 | TELO | Telomir Pharmaceuticals, Inc. | 79.78M | 3.57% | 64,230 | - |
| 399 | MNOV | MediciNova, Inc. | 79.74M | 13.29% | 111,261 | 920.48K |
| 400 | GANX | Gain Therapeutics, Inc. | 79.43M | 1.68% | 391,413 | - |
| 401 | ATHE | Alterity Therapeutics Limited | 79.40M | - | 13,255 | 2.50M |
| 402 | NRXS | NeurAxis, Inc. | 76.23M | 2.02% | 69,943 | 5.32M |
| 403 | CING | Cingulate Inc. | 75.91M | 1.36% | 82,368 | - |
| 404 | CSBR | Champions Oncology, Inc. | 73.36M | 2.52% | 11,813 | 59.43M |
| 405 | RNTX | Rein Therapeutics Inc. | 72.77M | 8.88% | 568,107 | - |
| 406 | LONA | LeonaBio, Inc. | 72.55M | 0.39% | 7,646 | - |
| 407 | SPRO | Spero Therapeutics, Inc. | 71.05M | - | 203,326 | 47.00M |
| 408 | PLRX | Pliant Therapeutics, Inc. | 69.97M | -2.59% | 299,288 | - |
| 409 | NTRB | Nutriband Inc. | 68.44M | 19.79% | 170,530 | 1.80M |
| 410 | SER | Serina Therapeutics, Inc. | 68.33M | 2.67% | 18,844 | 130.00K |
| 411 | XBIT | XBiotech Inc. | 67.07M | 0.46% | 136,190 | - |
| 412 | ELTX | Elicio Therapeutics, Inc. | 65.70M | -1.96% | 272,710 | - |
| 413 | BOLD | Boundless Bio, Inc. | 65.28M | -0.69% | 72,441 | - |
| 414 | BSEM | BioStem Technologies, Inc. | 64.44M | 1.98% | 100,393 | 34.59M |
| 415 | EDSA | Edesa Biotech, Inc. | 64.31M | - | 26,231 | - |
| 416 | ALPS | Alps Group Inc | 63.23M | - | 63,972 | 3.74M |
| 417 | EXOZ | eXoZymes, Inc. | 63.11M | 0.15% | 3,972 | -700.00 |
| 418 | INMB | INmune Bio Inc. | 63.00M | -3.40% | 149,806 | 50.00K |
| 419 | HRTX | Heron Therapeutics, Inc. | 62.65M | 5.47% | 1,314,568 | 151.18M |
| 420 | HYFT | MindWalk Holdings Corp. | 62.49M | -0.37% | 88,711 | 11.43M |
| 421 | APLM | Apollomics, Inc. | 61.51M | 2.41% | 5,367 | 8.84M |
| 422 | XLO | Xilio Therapeutics, Inc. | 59.35M | 2.04% | 6,571 | 64.09M |
| 423 | ANVS | Annovis Bio, Inc. | 58.80M | -18.82% | 7,332,095 | - |
| 424 | INKT | MiNK Therapeutics, Inc. | 57.31M | -0.88% | 3,213 | - |
| 425 | ELOX | Eloxx Pharmaceuticals, Inc. | 57.28M | -10.42% | 37,461 | - |
| 426 | MCRB | Seres Therapeutics, Inc. | 56.07M | 1.81% | 135,980 | 1.88M |
| 427 | IMA | ImageneBio, Inc. | 55.45M | -1.51% | 11,966 | 800.00K |
| 428 | CELU | Celularity Inc. | 52.97M | -1.61% | 363,696 | 26.55M |
| 429 | TIL | Instil Bio, Inc. | 51.95M | -0.39% | 6,456 | - |
| 430 | IBO | Impact BioMedical Inc. | 51.75M | -2.04% | 82,432 | 35.00K |
| 431 | HYPD | Hyperion DeFi, Inc. | 51.28M | 7.84% | 535,576 | 1.40M |
| 432 | IMMP | Immutep Limited | 49.84M | -4.65% | 132,709 | 13.79M |
| 433 | ATYR | aTyr Pharma, Inc. | 49.39M | 2.13% | 385,334 | 190.00K |
| 434 | TVGN | Tevogen Inc. | 46.69M | - | 5,562 | - |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 45.87M | -5.46% | 1,330,513 | 21.00M |
| 436 | VERU | Veru Inc. | 45.18M | -3.64% | 75,946 | 16.89M |
| 437 | GRCE | Grace Therapeutics, Inc. | 45.02M | - | 159,233 | - |
| 438 | MGX | Metagenomi Therapeutics, Inc. | 43.82M | - | 69,013 | 13.56M |
| 439 | MREO | Mereo BioPharma Group plc | 43.47M | 1.87% | 876,917 | 500.00K |
| 440 | KPTI | Karyopharm Therapeutics Inc. | 40.15M | -1.12% | 819,676 | 146.62M |
| 441 | FLNA | Filana Therapeutics, Inc. | 40.01M | -3.42% | 273,373 | - |
| 442 | ALGS | Aligos Therapeutics, Inc. | 38.84M | 0.16% | 42,077 | 31.52M |
| 443 | CRVO | CervoMed Inc. | 38.40M | -3.79% | 199,035 | 331.30K |
| 444 | RNAZ | TransCode Therapeutics, Inc. | 36.49M | 7.21% | 69,966 | - |
| 445 | NXTC | NextCure, Inc. | 35.89M | 6.67% | 161,561 | - |
| 446 | LITS | Lite Strategy, Inc. | 35.39M | - | 2,486,696 | - |
| 447 | KYNB | Kyntra Bio, Inc. | 34.38M | -0.47% | 12,430 | 4.62M |
| 448 | CNTX | Context Therapeutics Inc. | 33.35M | 0.08% | 1,441,396 | - |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 33.01M | 5.00% | 78,758 | 35.09M |
| 450 | ACTU | Actuate Therapeutics, Inc. | 32.90M | 5.38% | 474,036 | - |
| 451 | RADX | Radiopharm Theranostics Limited | 31.21M | -0.23% | 18,715 | 9.34M |
| 452 | QNCX | Quince Therapeutics, Inc. | 31.07M | -4.98% | 10,988 | - |
| 453 | IGC | IGC Pharma, Inc. | 30.86M | 0.88% | 349,306 | 1.11M |
| 454 | BCTX | BriaCell Therapeutics Corp. | 30.73M | -1.12% | 67,754 | - |
| 455 | BRNS | Barinthus Biotherapeutics plc | 29.39M | -3.18% | 37,842 | 14.97M |
| 456 | CVM | CEL-SCI Corporation | 28.32M | -2.42% | 117,062 | - |
| 457 | ESLA | Estrella Immunopharma, Inc. | 27.88M | -7.10% | 17,294 | - |
| 458 | NNVC | NanoViricides, Inc. | 26.20M | -1.71% | 307,013 | - |
| 459 | ABVC | ABVC BioPharma, Inc. | 25.92M | 15.67% | 183,351 | 797.92K |
| 460 | EVAX | Evaxion A/S | 25.69M | 0.33% | 39,611 | 7.49M |
| 461 | BYSI | BeyondSpring Inc. | 25.58M | 1.83% | 43,684 | 1.88M |
| 462 | ATOS | Atossa Therapeutics, Inc. | 25.25M | 2.85% | 56,692 | - |
| 463 | TCRX | TScan Therapeutics, Inc. | 25.14M | -2.68% | 3,092,974 | 7.11M |
| 464 | PTN | Palatin Technologies, Inc. | 24.70M | 1.87% | 534,544 | 12.88M |
| 465 | TVRD | Tvardi Therapeutics, Inc. | 24.68M | -1.60% | 98,760 | - |
| 466 | QNTM | Quantum BioPharma Ltd. | 24.05M | -4.22% | 114,172 | - |
| 467 | LTRN | Lantern Pharma Inc. | 23.91M | -3.11% | 248,721 | - |
| 468 | PLRZ | Polyrizon Ltd. | 23.51M | 0.40% | 134,417 | - |
| 469 | CYCN | Cyclerion Therapeutics, Inc. | 22.85M | 9.73% | 150,563 | 1.90M |
| 470 | JSPR | Jasper Therapeutics, Inc. | 22.84M | -2.62% | 364,608 | - |
| 471 | ALLR | Allarity Therapeutics, Inc. | 22.75M | 1.42% | 44,209 | 345.00K |
| 472 | CNSY | Cerenome, Inc. | 22.62M | 1.36% | 42,412 | 4.20M |
| 473 | GNTA | Genenta Science S.p.A. | 22.42M | -2.82% | 52,237 | - |
| 474 | CLRB | Cellectar Biosciences, Inc. | 22.21M | -3.29% | 70,008 | - |
| 475 | COCP | Cocrystal Pharma, Inc. | 21.77M | -2.59% | 29,248 | 330.00K |
| 476 | AKTX | Akari Therapeutics, Plc | 21.11M | 6.80% | 61,947 | - |
| 477 | GRDX | GridAI Technologies Corp. | 21.03M | -14.16% | 213,408 | - |
| 478 | LGVN | Longeveron Inc. | 20.98M | -2.95% | 43,963 | 1.19M |
| 479 | MRKR | Marker Therapeutics, Inc. | 20.67M | -0.80% | 43,435 | 3.55M |
| 480 | CMMB | Chemomab Therapeutics Ltd. | 20.51M | 3.66% | 150,843 | - |
| 481 | LEXX | Lexaria Bioscience Corp. | 20.36M | -6.74% | 74,765 | 194.00K |
| 482 | NEUP | Neuphoria Therapeutics Inc. | 20.32M | 0.27% | 7,462 | -13.27K |
| 483 | ENLV | Enlivex Ltd. | 20.28M | -7.20% | 293,981 | - |
| 484 | LPCN | Lipocine Inc. | 19.95M | 2.76% | 26,672 | 1.57M |
| 485 | KTTA | Pasithea Therapeutics Corp. | 19.39M | 0.02% | 124,443 | - |
| 486 | NCEL | NewcelX Ltd. | 19.35M | - | 9,009 | - |
| 487 | NIKI | Niki BioSolutions, Inc. | 19.13M | -1.51% | 5,867 | - |
| 488 | DYAI | Dyadic International, Inc. | 18.24M | -4.48% | 309,224 | 3.80M |
| 489 | ADIL | Adial Pharmaceuticals, Inc. | 17.49M | 5.38% | 52,800 | - |
| 490 | PBM | Psyence Biomedical Ltd. | 16.90M | 1.37% | 21,419 | - |
| 491 | TPST | Tempest Therapeutics, Inc. | 16.78M | -4.55% | 182,258 | - |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 16.53M | 3.88% | 250,736 | 7.11M |
| 493 | BCDA | BioCardia, Inc. | 16.50M | -1.80% | 169,601 | 3.00K |
| 494 | QNRX | Quoin Pharmaceuticals, Ltd. | 15.81M | 16.77% | 439,231 | - |
| 495 | HIND | Vyome Holdings, Inc. | 15.65M | 2.29% | 14,443 | 129.73K |
| 496 | BIVI | BioVie Inc. | 15.31M | - | 250,795 | - |
| 497 | PASG | Passage Bio, Inc. | 15.28M | 3.04% | 8,030 | - |
| 498 | CALC | CalciMedica, Inc. | 15.02M | 4.76% | 94,777 | - |
| 499 | MLEC | Moolec Science SA | 14.85M | 4.85% | 21,226 | 7.83M |
| 500 | NRSN | NeuroSense Therapeutics Ltd. | 14.85M | -2.24% | 85,673 | - |